(Q35194191)

7 August 2017

1 reference

title

Japanese encephalitis vaccines: moving away from the mouse brain (English)

1 reference

Japanese encephalitis virus

7 August 2017

main subject

0 references

Japanese encephalitis

1 reference

1 reference

4

Steven L Wesselingh

1 reference

7 August 2017

Mark P Zanin

1

1 reference

7 August 2017

Diane E Webster

series ordinal

2

1 reference

7 August 2017

Jenny L Martin

series ordinal

3

1 reference

7 August 2017

publication date

1 June 2003

1 reference

Expert Review of Vaccines

7 August 2017

published in

1 reference

7 August 2017

volume

2

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

407-416

1 reference

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Flavivirus genome organization, expression, and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Allergic mucocutaneous reactions to Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Anaphylaxis to Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

21 January 2018

Yellow fever vaccines

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

A Japanese Encephalitis Virus Peptide Present on Johnson Grass Mosaic Virus-Like Particles Induces Virus-Neutralizing Antibodies and Protects Mice against Lethal Challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Inoculation of Plasmids Encoding Japanese Encephalitis Virus PrM-E Proteins with Colloidal Gold Elicits a Protective Immune Response in BALB/c Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Mucosal delivery of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Oral immunisation of mice with live Japanese encephalitis virus induces a protective immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

The prime-boost strategy: exciting prospects for improved vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.407

21 January 2018

Identifiers

DOI

10.1586/14760584.2.3.407

1 reference

7 August 2017

1 reference